Remission Induction in Patients with Lymphoid Malignancies Using Unconjugated CAMPATH-1 Monoclonal Antibodies.

Remission Induction in Patients with Lymphoid Malignancies Using Unconjugated CAMPATH-1 Monoclonal Antibodies.

Item
http://www.wikidata.org/entity/Q41748357
A phase II multicenter study of CAMPATH-1H antibody in previously treated patients with nonbulky non-Hodgkin's lymphoma.Autoimmune thrombocytopenic purpura complicating lymphoproliferative disorders.Human peripheral blood mononuclear cells exhibit heterogeneous CD52 expression levels and show differential sensitivity to alemtuzumab mediated cytolysis.Treatment options in Waldenström's macroglobulinaemia: the role of the purine analogues.CD52-Negative NK Cells Are Abundant in the Liver and Less Susceptible to Alemtuzumab Treatment.Monoclonal antibody therapy of leukaemias and lymphomas.Eradication of minimal residual disease with alemtuzumab in B-cell chronic lymphocytic leukemia (B-CLL) patients: the need for a standard method of detection and the potential impact of bone marrow clearance on disease outcome.Alemtuzumab use in relapsed and refractory chronic lymphocytic leukemia: a history and discussion of future rational useImmunosuppressive toxicity of CAMPATH1H monoclonal antibody in the treatment of patients with recurrent low grade lymphoma.In vitro and preclinical studies of targeted alpha therapy (TAT) for colorectal cancer.Low-dose alemtuzumab (Campath) in myeloablative allogeneic stem cell transplantation for CD52-positive malignancies: decreased incidence of acute graft-versus-host-disease with unique pharmacokinetics.Monoclonal antibodies in the treatment of human B-cell malignancies.
P2860

Remission Induction in Patients with Lymphoid Malignancies Using Unconjugated CAMPATH-1 Monoclonal Antibodies.

Item
http://www.wikidata.org/entity/Q41748357
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
1990年论文
@zh
1990年论文
@zh-cn
name
Remission Induction in Patient ...... MPATH-1 Monoclonal Antibodies.
@en
type
label
Remission Induction in Patient ...... MPATH-1 Monoclonal Antibodies.
@en
prefLabel
Remission Induction in Patient ...... MPATH-1 Monoclonal Antibodies.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P356
P1433
P1476
Remission Induction in Patient ...... AMPATH-1 Monoclonal Antibodies
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698